HRA Pharma Articles
Cushing’s syndrome patients to receive safer drug options
22 February 2012
HRA Pharma in deal with Chemo Iberica for ulipristal emergency contraceptive in Latin America
22 December 2010
HRA Pharma’s ellaOne now reimbursed in France
21 September 2010
Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal
18 June 2010
Showing 1-5 of 5 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
